Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announced that it has submitted a Clinical Trial Application to initiate a Phase 1/2 clinical trial of OTOF-GT in Europe.
